Meindert Boysen, PharmD, is the director for the technology appraisal and the highly specialized technologies programs at the National Institute for Health and Care Excellence (NICE) in England, UK. Meindert is also responsible for the Patient Access Schemes Liaison Unit, and the NICE side of the Cancer Drugs Fund.

Meindert has graduated in PharmD and completed a masters in health policy planning and financing at the London School of Hygiene and Tropical Medicine and the London School of Economics and Political Science.

He has worked in hospital pharmacy, in pharmaceutical industry (Eli Lilly & Co), for the King's Fund, and NICE.